NBC Daily Forex: May 28, 2013

Published 05/28/2013, 08:39 AM
Updated 05/14/2017, 06:45 AM

On Monday, Quebec-based Valeant Pharmaceuticals signed an agreement to acquire U.S. eye care specialist Bausch + Lomb for the hefty sum of $8.7 billion. According to the Wall Street Journal, a major part of the acquisition will be financed by debt issues, with the balance of $1.5 to 2 billion to be be funded by new shares. Although many of the details of the acquisition have yet to be defined, it is possible that greater capital flows would affect the USD/CAD pairing in upcoming sessions.

The U.S. Consumer Confidence Index figures for May will be released at 10 a.m. Markets are expecting the index to rebound slightly, from 68.1 in April to 71.0. On top of the other positive data from south of the border, this would be good news for the Canadian dollar in contrast with the current lacklustre economic outlook at home. A strong increase would force the loonie to revisit last week’s highs. On the eve of the Bank of Canada’s Key Interest Rate decision, we recommend you review the level of your orders with your trader. Wishing you a great day. Xavier Villemaire

Range of the day: 1.0300 - 1.0400

Economic Data

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.